• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. ENDOBON XENOGRAFT GRANULATES LARGE 5 ML; BONE GRAFTING MATERIAL, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. ENDOBON XENOGRAFT GRANULATES LARGE 5 ML; BONE GRAFTING MATERIAL, SYNTHETIC Back to Search Results
Model Number N/A
Medical Device Problem Code Failure to Osseointegrate (1863)
Health Effect - Clinical Codes Inflammation (1932); Inadequate Osseointegration (2646)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the implant failed to heal after sinus lift procedure.Due diligence is in progress for this complaint; to date no additional information or product has been received.
 
Additional Manufacturer Narrative
(b)(4).G2 foreign austria.Investigation of this incident is currently ongoing.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Additional Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.Visual inspection of the returned product from the same batch show no specific issue.Products are intact.No issue found.A review of the device manufacturing records confirmed no abnormalities or deviations.Device is used for treatment.Medical records were not provided.With the available information, a definitive root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No further event information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOBON XENOGRAFT GRANULATES LARGE 5 ML
Common Device Name
BONE GRAFTING MATERIAL, SYNTHETIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key17150576
Report Number3006946279-2023-00060
Device Sequence Number19818751
Product Code LYC
UDI-Device Identifier03599870097571
UDI-Public(01)03599870097571(17)230531(10)AB0132350
Combination Product (Y/N)N
Initial Reporter CountryAU
PMA/510(K) Number
K110449
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Dentist
Type of Report Initial,Followup
Report Date (Section B) 09/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date05/31/2023
Device Model NumberN/A
Device Catalogue NumberROXLG50
Device Lot NumberAB0132350
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/22/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/22/2023
Supplement Date Received by Manufacturer09/27/2023
Initial Report FDA Received Date06/19/2023
Supplement Report FDA Received Date09/28/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/14/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexPrefer Not To Disclose
-
-